171 related articles for article (PubMed ID: 30585791)
1. Modifier genes in cystic fibrosis-related liver disease.
Debray D; Corvol H; Housset C
Curr Opin Gastroenterol; 2019 Mar; 35(2):88-92. PubMed ID: 30585791
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of liver disease in cystic fibrosis.
Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
[TBL] [Abstract][Full Text] [Related]
3. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
Boëlle PY; Debray D; Guillot L; Corvol H;
Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis-associated liver disease in children.
Wasuwanich P; Karnsakul W
Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
[TBL] [Abstract][Full Text] [Related]
5. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
[TBL] [Abstract][Full Text] [Related]
6. Cystic Fibrosis Liver Disease: Know More.
Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis related liver disease and endocrine considerations.
Sherwood JS; Ullal J; Kutney K; Hughan KS
J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
Fiorotto R; Strazzabosco M
Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease.
Frangolias DD; Ruan J; Wilcox PJ; Davidson AG; Wong LT; Berthiaume Y; Hennessey R; Freitag A; Pedder L; Corey M; Sweezey N; Zielenski J; Tullis E; Sandford AJ
Am J Respir Cell Mol Biol; 2003 Sep; 29(3 Pt 1):390-6. PubMed ID: 12689922
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
[TBL] [Abstract][Full Text] [Related]
13. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
Scott J; Jones AM; Piper Hanley K; Athwal VS
Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.
Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F
PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930
[TBL] [Abstract][Full Text] [Related]
16. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
[TBL] [Abstract][Full Text] [Related]
17. Emerging clinical perspectives in cystic fibrosis liver disease.
Athwal VS; Scott JA; Fitzpatrick E; Rowland M
Curr Opin Pulm Med; 2021 Nov; 27(6):593-599. PubMed ID: 34482340
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
Cook NL; Pereira TN; Lewindon PJ; Shepherd RW; Ramm GA
J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
[TBL] [Abstract][Full Text] [Related]
20. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
Terlizzi V; Lucarelli M; Salvatore D; Angioni A; Bisogno A; Braggion C; Buzzetti R; Carnovale V; Casciaro R; Castaldo G; Cirilli N; Collura M; Colombo C; Di Lullo AM; Elce A; Lucidi V; Madarena E; Padoan R; Quattrucci S; Raia V; Seia M; Termini L; Zarrilli F
BMC Pulm Med; 2018 Dec; 18(1):196. PubMed ID: 30577776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
